目的 探讨品管圈管理在提高住院麻醉药品处方合格率的应用效果。方法 组建品管圈,利用80/20法则和鱼骨图探讨我院住院麻醉药品处方不合格的原因,确定提高处方合格率的对策,通过对策的实施与检讨,比较品管圈管理前后的处方合格率变化。结果 利用品管圈管理,2018年我院住院麻醉药品处方质量显著提高,合格率由2017年的70.07%提高到2018年97.78%,高于目标值6.69%。持续品管圈管理后,2019年前三季度处方合格率提高到99.33%。结论 品管圈活动的开展能够有效地提升住院麻醉药品处方的合格率,既规范了麻醉药品的使用、促进患者用药安全,又提高了药师综合素养和医院药学服务的质量。
Abstract
OBJECTIVE To explore the application effect of quality control circle management in improving the qualified rate of anesthetic drugs prescription in hospital. METHODS The quality control circle was established to explore the causes of the unqualified anesthetic drugs prescription in our hospital by using the 80/20 rule and fish-bone diagram. The measures to improve the prescription pass rate were determined, and the changes of the prescription pass rate before and after QCC management were compared through the implementation and review of the measures. RESULTS Using the management of quality control circle, the prescription quality of inpatient anesthetic drugs was significantly improved in our hospital in 2018 and the qualified rate increased from 70.07% in 2017 to 2018 97.78% above target value of 6.69%. After continuous quality control circle management, the qualified rate of prescription increased to 99.33% in the first three quarters of 2019. CONCLUSION The development of QCC can effectively improve the qualified rate of anesthetic drugs prescription in hospital, not only standardizing the use of anesthetic drugs, promoting drug safety of patients, but also improving the comprehensive quality of pharmacists and the quality of hospital pharmaceutical care.
关键词
品管圈 /
麻醉药品 /
住院处方 /
处方点评
{{custom_keyword}} /
Key words
quality control circle /
narcotic drug /
hospitalization prescription /
prescription comment
{{custom_keyword}} /
中图分类号：
R969
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] LU Z C, XU H Y, ZHANG X, et al. Application research of quality control circle in reducing the rate of dispensing error of automatic dispenser[J]. Clin J Hosp Pharm (中国医院药学杂志), 2019,39(7):741-745.
[2] XIAO L F, LI X P, SHI Y, et al. The application of quality control circle to reduce the incidence of pharmaceutical risk related to intravenous infusion[J]. Clin J Hosp Pharm(中国医院药学杂志), 2019,39(5):512-520.
[3] ZHANG G R,LI H T,LIU L. Analysis on application of narcotics and psychotropic drugs of categoryⅠ in Beijing Fengsheng Special Hospital of traditional medical traumatology and orthopedics during 2012-2017[J]. Eval Anal Drug Use Hosp China (中国医院用药评价与分析), 2018,18(9):1253-1258.
[4] LIU Y,WU X M,GU J Q. Analysis of narcotic drug use in China from 2003 to 2013[J]. Chin Pharm J (中国药学杂志), 2015,50(5):469-472.
[5] YAO P, GUAN X D, DENG Y P, et al. An overview of management of narcotics and psychotropic drugs in China[J]. J Chin Pharm Sci (中国药学英文版), 2014,24(4):250-256.
[6] LU Y L,YAN M. Use of the American experiences for reference on the intervention of pharmacists to prescribing behavior in China[J]. Chin Pharm J(中国药学杂志), 2018,53(24):2132-2136.
[7] HUANG F, QIAN X P. Review and analysis on 2 246 prescriptions with narcotic drugs evaluation and analysis of drug-use in hospitals of China[J]. Eval Anal Drug Use Hosp China(中国医院用药评价与分析), 2017,17(11):1577-1579.
[8] XIAO Y. Investigation and analysis of drug use in the hospital from 2013 to 2015[J]. China Pharm(中国药业), 2016,25(20):72-74.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(3702 KB)
